247 related articles for article (PubMed ID: 23836045)
1. New directions for HIV vaccine development from animal models.
McChesney MB; Miller CJ
Curr Opin HIV AIDS; 2013 Sep; 8(5):376-81. PubMed ID: 23836045
[TBL] [Abstract][Full Text] [Related]
2. Role of nonhuman primates in the evaluation of candidate AIDS vaccines: an industry perspective.
Staprans SI; Feinberg MB; Shiver JW; Casimiro DR
Curr Opin HIV AIDS; 2010 Sep; 5(5):377-85. PubMed ID: 20978377
[TBL] [Abstract][Full Text] [Related]
3. The roles of nonhuman primates in the preclinical evaluation of candidate AIDS vaccines.
Staprans SI; Feinberg MB
Expert Rev Vaccines; 2004 Aug; 3(4 Suppl):S5-32. PubMed ID: 15285703
[TBL] [Abstract][Full Text] [Related]
4. Nonhuman primate models for the evaluation of HIV-1 preventive vaccine strategies: model parameter considerations and consequences.
Del Prete GQ; Lifson JD; Keele BF
Curr Opin HIV AIDS; 2016 Nov; 11(6):546-554. PubMed ID: 27559710
[TBL] [Abstract][Full Text] [Related]
5. Towards an AIDS vaccine: the role of nonhuman primates.
Nathanson N; Mathieson BJ
J Med Primatol; 1999; 28(4-5):146-53. PubMed ID: 10593479
[TBL] [Abstract][Full Text] [Related]
6. HIV vaccine development: strategies for preclinical and clinical investigation.
Shapiro SZ
AIDS Res Hum Retroviruses; 2013 Nov; 29(11):1401-6. PubMed ID: 23379343
[TBL] [Abstract][Full Text] [Related]
7. Efficacy of AIDS vaccine strategies in nonhuman primates.
Uberla K
Med Microbiol Immunol; 2005 Aug; 194(4):201-6. PubMed ID: 15843997
[TBL] [Abstract][Full Text] [Related]
8. Worldwide survey of AIDS vaccine challenge studies in nonhuman primates: vaccines associated with active and passive immune protection from live virus challenge.
Warren JT; Dolatshahi M
J Med Primatol; 1992; 21(2-3):139-86. PubMed ID: 1433265
[TBL] [Abstract][Full Text] [Related]
9. Nonhuman primate models for HIV vaccine development.
Letvin NL
Immunodefic Rev; 1992; 3(3):247-60. PubMed ID: 1510838
[TBL] [Abstract][Full Text] [Related]
10. Preclinical AIDS vaccine development: formal survey of global HIV, SIV, and SHIV in vivo challenge studies in vaccinated nonhuman primates.
Warren JT; Levinson MA
J Med Primatol; 1997; 26(1-2):63-81. PubMed ID: 9271191
[No Abstract] [Full Text] [Related]
11. Low-dose penile SIVmac251 exposure of rhesus macaques infected with adenovirus type 5 (Ad5) and then immunized with a replication-defective Ad5-based SIV gag/pol/nef vaccine recapitulates the results of the phase IIb step trial of a similar HIV-1 vaccine.
Qureshi H; Ma ZM; Huang Y; Hodge G; Thomas MA; DiPasquale J; DeSilva V; Fritts L; Bett AJ; Casimiro DR; Shiver JW; Robert-Guroff M; Robertson MN; McChesney MB; Gilbert PB; Miller CJ
J Virol; 2012 Feb; 86(4):2239-50. PubMed ID: 22156519
[TBL] [Abstract][Full Text] [Related]
12. HIV-1 vaccines and adaptive trial designs.
Corey L; Nabel GJ; Dieffenbach C; Gilbert P; Haynes BF; Johnston M; Kublin J; Lane HC; Pantaleo G; Picker LJ; Fauci AS
Sci Transl Med; 2011 Apr; 3(79):79ps13. PubMed ID: 21508308
[TBL] [Abstract][Full Text] [Related]
13. Prospects for a globally effective HIV-1 vaccine.
Excler JL; Robb ML; Kim JH
Vaccine; 2015 Nov; 33 Suppl 4():D4-12. PubMed ID: 26100921
[TBL] [Abstract][Full Text] [Related]
14. Challenges in mucosal HIV vaccine development: lessons from non-human primate models.
Tuero I; Robert-Guroff M
Viruses; 2014 Aug; 6(8):3129-58. PubMed ID: 25196380
[TBL] [Abstract][Full Text] [Related]
15. Complex immune correlates of protection in HIV-1 vaccine efficacy trials.
Tomaras GD; Plotkin SA
Immunol Rev; 2017 Jan; 275(1):245-261. PubMed ID: 28133811
[TBL] [Abstract][Full Text] [Related]
16. Predictive value of primate models for AIDS.
Haigwood NL
AIDS Rev; 2004; 6(4):187-98. PubMed ID: 15700617
[TBL] [Abstract][Full Text] [Related]
17. A critical analysis of the cynomolgus macaque, Macaca fascicularis, as a model to test HIV-1/SIV vaccine efficacy.
Antony JM; MacDonald KS
Vaccine; 2015 Jun; 33(27):3073-83. PubMed ID: 25510387
[TBL] [Abstract][Full Text] [Related]
18. HIV vaccine development at the turn of the 21st century.
Girard MP; Plotkin SA
Curr Opin HIV AIDS; 2012 Jan; 7(1):4-9. PubMed ID: 22156840
[TBL] [Abstract][Full Text] [Related]
19. Vaccine development against HIV-1: current perspectives and future directions.
Edgeworth RL; San JH; Rosenzweig JA; Nguyen NL; Boyer JD; Ugen KE
Immunol Res; 2002; 25(1):53-74. PubMed ID: 11868934
[TBL] [Abstract][Full Text] [Related]
20. Development of replication-competent viral vectors for HIV vaccine delivery.
Parks CL; Picker LJ; King CR
Curr Opin HIV AIDS; 2013 Sep; 8(5):402-11. PubMed ID: 23925000
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]